At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
High Frequency Chest Wall Oscillatordevice
Likely dose
High Frequency Chest Wall Oscillator — high velocity, low amplitude oscillatory airflow applied via pneumatic vestAI-extracted
Key inclusion· 4
- ✓Age 18 years or older
- ✓Admitted to inpatient medical service (not ICU)
- ✓Physician-diagnosed asthma, asthma/COPD overlap, or COPD exacerbation
- ✓Spirometry-documented airflow obstruction
Key exclusion· 8
- ✕More than 24 hours since inpatient admission
- ✕ICU admission
- ✕Planned discharge within 24 hours
- ✕Other chronic respiratory diseases (e.g., sarcoidosis, idiopathic pulmonary fibrosis)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)
In Brief
A clinical study evaluating High Frequency Chest Wall Oscillator for Asthma and 2 related conditions. Completed, enrolled 52 participants across 1 site.
Detailed Summary
The objective of this study was to evaluate the use of high frequency chest wall oscillation (HFCWO) early in the treatment of adults hospitalized for acute asthma or chronic obstructive pulmonary disease (COPD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsHill-Rom
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2003
First PostedSep 2005
Primary CompletionMay 2008
TodayJul 2026
First PostedSep 16, 2005
Enrollment StartOct 1, 2003
Primary CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 20.8 years ago
Interventions
High Frequency Chest Wall Oscillatordevice
High velocity, low amplitude oscillatory airflow applied through a pneumatic vest worn over the thorax